FT US Healthcare and Life Sciences Conference

In association with:

About Life Sciences and Health Care at Deloitte*

Deloitte’s life sciences and health care (LSHC) industry group is composed of more than 7,600 professionals in over 70 countries. These professionals understand the complexity of today’s life sciences and health care industry challenges, and provide clients with integrated, comprehensive services that meet their respective needs. In today’s environment, LSHC professionals from across the Deloitte network help companies to evolve in a changing marketplace, pursue new and innovative solutions, and sustain long-term profitability.

For more information about the DTTL LSHC industry group, email dttlshc@deloitte.com or access www.deloitte.com/lifesciences.

*Deloitte refers to one or more of Deloitte Touche Tohmatsu Limited (DTTL), a UK private company limited by guarantee, and its network of member firms, each of which is a legally separate and independent entity.

Lead Sponsors:

GNS Healthcare integrates massive quantities of patient data to build models that predict what works in healthcare, and for whom. Our models are unique in their ability to produce data-driven evidence of causation, which goes beyond correlation to reveal the underlying cause and effect relationships between treatments, patient characteristics, and clinical and economic outcomes. We deliver software tools that allow you to explore the models and rapidly produce new answers and insights into your questions.

Our analytics solutions are being used by leaders across healthcare, from pharmaceutical R&D, HEOR and marketing to payers, providers, government, and academic institutions.  We empower healthcare executives to make data-driven decisions on the most important issues facing their businesses, from the individual patient level to the healthcare system level. From identifying the best intervention for an individual patient to refining benefit design, GNS helps our partners improve patient outcomes and reduce costs. 

The National Institute for Health Research Clinical Research Network is the clinical research delivery arm of the NHS.

Funded by government, it provides an infrastructure of research nurses and clinicians in hospitals and doctor's surgeries across England, to support the timely recruitment of patients into clinical research, including life-sciences industry studies.

The Network also works closely with industry partners to develop and implement tools and services to streamline study set-up, provide intelligence on local patient populations, clinicians and facilities, and improve the performance of commercial clinical trials to time and target.  Such tools include standard costing templates and contracts, which dramatically reduce the amount of time companies spend in negotiations to conduct trials.

Last year, the Clinical Research Network delivered its highest ever number of commercial contract research studies, increased patient recruitment to commercial studies by 20% and doubled the number of studies delivered to time and target. www.crncc.nihr.ac.uk


Supporting Partners: 

BioPharm Insight is your definitive guide to the global life sciences community. Subscribers take action on forward-looking intelligence uncovered by an independent team of investigative journalists, and make strategic business decisions using the most comprehensive and powerful real-time database of market analytics and key contacts. Featuring an intuitive online interface and exclusive Active Intel relational content technology, BioPharm Insight provides an unrivaled capability to segment and analyze the industry with detailed and searchable profiles. www.biopharminsight.com

BioPortfolio is a leading news, information and knowledge resource covering the global life science industries impacted on by biotechnology. The site aims to provide the lay person, the researcher and the management executive with a single location to source core information on specific bio-related topics, to collate relevant data associated with each topic and to point the user to relevant knowledge resources. www.bioportfolio.com

MDMA is the voice representing the interests of innovative and entrepreneurial medical technology companies. We provide educational and advocacy assistance to approximately 300 members. MDMA members all share a common goal: to provide patients and clinicians with timely access to safe and effective medical technologies that improve the quality of life. www.medicaldevices.org